28. We thank J. Cerny and M. Schlissel for their review of this manuscript; S. V. Desiderio for RAG2-specific antibody; R. Hodes, K. Holmes, and A. An important feature of the human immune system is the ability of T cells to respond to small quantities of antigen. Class II major histocompatibility complex (MHC)-restricted T cells that expressed a costimulatory natural killer (NK) cell receptor for class I MHC proteins were cloned. In the presence of low doses of superantigen, the proliferative response of these T cell clones was three-to ninefold greater when the T cells were costimulated by way of the NK receptor. Thus, the action of costimulatory NK receptors on T cells may play a significant role in initiating and sustaining immune responses.
T cells recognize antigens through contacts made between the T cell receptor (TCR) and peptides presented in association with specific MHC proteins on an antigen-presenting cell (APC). However, the T lymphocyte response is also shaped by many other interactions between cell-surface molecules on T cells and APCs, as well as by the action of cytokines (1). Although no distinct "antigen receptor" analogous to the TCR has been found on NK cells, NK cell-mediated lysis can be inhibited by NK receptors that also bind to class I MHC proteins (2, 3) . In particular, lysis by NK1 and NK2 cells is inhibited by target cells expressing human leukocyte antigen (HLA)-Cw2, -Cw4, -Cw5, or -Cw6 and HLA-Cw1, -Cw3, -Cw7, or -Cw8, respectively (4, 5) . Also, lysis by NKB1 ϩ NK3 cells is inhibited by target cells expressing an HLA-B allele containing the Bw4 epitope at residues 77 to 83 (6) . Such inhibition is initiated by the recruitment of protein tyrosine phosphatases on the cytoplasmic tail of the NK receptor (7) . T cells share with NK cells a common lineage and many phenotypic markers (8) including NK inhibitory receptors. Indeed, ϳ28% of cytotoxic T cells express p58 NK inhibitory receptors (9) , and the p70 NK inhibitory receptor, NKB1, is expressed on 0.2 to 15% of T cells (10) . The action of these NK inhibitory receptors can affect T cell function because NKB1 ϩ T cell clones that can kill superantigen-coated target cells cannot kill the same target cells transfected with class I MHC alleles expressing the Bw4 epitope (10) .
Recently, an isoform of NK inhibitory receptors was described. These p50 NK receptors share similar extracellular sequences with the p58 receptors but have altered transmembrane regions, including the addition of a charged lysine residue, and truncated cytoplasmic tails (3, 11) , so that they lack the YXXL sequences (L, Leu; Y, Tyr; X, any amino acid) to which protein tyrosine phosphatases can bind. Such short-tailed NK receptors do not mediate inhibition of NK cell-mediated lysis but instead activate or coactivate NK clones (11) . To investigate the possible effect of NK activating receptors on T cell function, we studied T cell clones isolated as by-products in NK cell cloning (12) .
Two of these clones, TANK-1 and TANK-9, were prepared from a donor whose HLA type is HLA-A1, -A2, -B7, -B8, -Cw7, -DR1, -DR17, -DQw2, and -DQw5. Clone TANK-1 was positive for TCRBV17 (V ␤ 17) and expressed neither NK1, NK2, nor NK3 receptors by flow cytometry (13) . Cloning by polymerase chain reaction (PCR) and sequencing of cDNA derived from TANK-1 (14) revealed the expression of the short-tailed activating NK receptor, clone 39 (3). Clone TANK-9 was positive for TCRBV2 (V ␤ 2) and expressed both NK1 and NK2 receptors by flow cytometry (13) . PCR typing of cDNA derived from TANK-9 (15) revealed that TANK-9 expresses the activating, short-tailed form of the NK1 receptor (NKAR1) and the inhibitory, long-tailed form of the NK2 receptor (NKIR2), as well as TCRVA24 (V ␣ 24). These T cells with activating NK receptors (TANK cells) were positive for TCR␣␤, CD4, and CD3 and negative for TCR␥␦, CD8, CD16, CD56, and CD94 by flow cytometry (13, 16) .
To determine the effect of NK activating receptors on T cell responses, we examined the proliferative response of TANK-1 and TANK-9 in the presence of superantigen-coated 721.221 cells, human HLA-DR1 ϩ B cells deficient in cell-surface expression of class I MHC proteins (17) , and 721.221 transfectants (18) . As expected from the TCRVB gene segment expressed by each clone, TANK-9 responded to toxic shock syndrome toxin 1 (TSST1) (Fig. 1A ) and not to staphylococcal enterotoxin A (SEA) or SEB (19) , whereas TANK-1 responded to SEB (Fig. 1B) and not to SEA (19) . At all the tested concentrations of TSST1, the proliferation of TANK-9 was greater when the target cell was transfected with either HLA-Cw4 or -Cw6 and reduced when the target cell was transfected with either HLA-Cw3 or -Cw7 (Fig. 1A) .
Target cells that enhanced the proliferative response expressed class I MHC proteins that were recognized by NK1 receptors, whereas target cells that inhibited the response expressed alleles that were recognized by NK2 receptors (9, 11) . This result implies that the short-tailed NK1 receptor present on the cell surface of TANK-9 facilitates the enhancement of the T cell proliferative response, whereas the longtailed NK2 receptor mediates inhibition of such a response. The decrease in proliferation of TANK-9 in response to TSST1 at 50 ng/ml compared to the proliferative response at 0.5 ng/ml is likely to be due to the induction of anergy (20) .
Proliferation of TANK-1 in response to SEB presentation was enhanced by target cells transfected with either HLA-Cw4 or In all experiments, each data point was measured in triplicate. The range in each measurement was less than 5% of the mean of the triplicates. The 721.221 transfectants were generated as in (5) . The experiment shown here is representative of six data sets that were obtained. In the absence of superantigen, less than 400 cpm were measured regardless of the type of B cell or T cell present. Proliferation of TANK-1 stimulated by SEB (0.5 ng/ml) was measured in the presence of 721.221 cells or 721.221 transfectants plus the antibody to class I MHC proteins (PA2.6) or an isotype control (MOPC21, Sigma). To show the largest possible effect of blocking NK receptor ligation with PA2.6, we harvested the cells 3 days after incubation. Otherwise, proliferation assays were done as described (18) . Each data point was measured in duplicate. The range in each measurement was less than 10% of the mean of the duplicates. The experiments shown here are representative of three data sets that were obtained.
SCIENCE ⅐ VOL. 274 ⅐ 20 DECEMBER 1996 HLA-Cw7 (Fig. 1B) . Two other TANK cell clones behaved similarly (19) . Because the only NK receptor expressed on TANK-1 was the activating receptor, clone 39, it can be inferred that clone 39 facilitates an enhanced T cell response in the presence of the class I MHC alleles HLA-Cw4 and HLA-Cw7. These two class I MHC proteins belong to the two distinct groups of HLA-C proteins that are recognized by either NK1 or NK2 receptors. The molecular basis for the recognition of both HLA-Cw4 and -Cw7 by clone 39 is unknown, but the sequence of clone 39 is chimeric between NKAR1 and NKAR2.
The costimulatory effect of HLA-Cw4 or -Cw7 on the proliferative response of TANK-1 is greatest at lower concentrations of superantigen, causing a 300 to 900% increase in stimulation compared with untransfected target cells (Figs. 1, B and C,  and 2A) . Thus, the function of costimulatory NK receptors on T cells in vivo might be to allow a subset of T cells to be particularly responsive to small quantities of antigen. In addition, the enhanced T cell response of TANK-1 costimulated by HLACw4 or -Cw7 peaks on the fourth day after initial stimulation and is maintained for a further 5 days (Fig. 1C) . This suggests that the function of the costimulatory NK receptor on T cells might also be to sustain the immune response for an extended period. Possible reasons for the sharp decrease in the proliferation of TANK-1 at about 5 days after initial stimulation (Fig. 1C) include the up-or down-regulation of a particular protein on either the T cells or target cells, depletion of cytokines, or an exhaustion of nutrients within the media.
To determine directly whether the activating NK receptor on T cells facilitates the enhancement in proliferation, we used the monoclonal antibodies (mAbs) HP3E4 and GL183 to NK1 and NK2, respectively, in assays of TANK-9 proliferation in the presence of TSST1 at 0.05 ng/ml. Monoclonal antibody HP3E4 blocked the enhancement of TANK-9 proliferation mediated by 721.221 cells transfected with HLA-Cw4 or -Cw6, and GL183 blocked the inhibition of TANK-9 mediated by HLA-Cw3-or HLACw7-expressing target cells (Fig. 2A) . Analogous data were obtained with superantigen at 0.5 ng/ml. These data confirm that the NK1 and NK2 receptors on TANK-9 do indeed mediate the alterations in the proliferative response to TSST1.
Because none of the available mAbs binds specifically to clone 39, the role of this molecule in enhancing the proliferative response of TANK-1 could not be directly assessed by antibody blocking. However, the increase in proliferation of TANK-1 in the presence of SEB at 0.5 ng/ml, mediated by 721.221 cells transfected with HLA-Cw4 or -Cw7, was blocked by mAb PA2.6 to class I MHC proteins (Fig. 2B) . Analogous data were obtained with SEB at 0.05 ng/ml. These data confirm that the increased proliferation of TANK-1 is mediated by class I MHC receptors.
The nonclassical class I MHC protein, HLA-G, has recently been shown to inhibit both NK1 and NK2 clones (21) . Transfection of HLA-G into 721.221 cells enhanced the proliferation of TANK-1 in the presence of SEB, compared to untransfected cells (Fig.  3A) . In contrast, the carcinoma cell line JEG-3, which expresses HLA-G but is deficient in class II MHC expression, could not stimulate TANK-1 in the presence of SEB (Fig. 3A) . This result implies that superantigen cannot be presented by the class I MHC protein to cause significant proliferation of TANK-1, and that stimulation must be mediated primarily by superantigen associated with class II MHC molecules. In support of this conclusion, the proliferative response of TANK-1 to SEB was diminished in the presence of mAb LB3.1 to class II MHC (19) .
SEB-coated 721.221 cells that had been transfected with HLA-G but that had lost most cell-surface expression of the protein after an extended period in culture (HLA-G [2] ) caused the same extent of TANK cell proliferation as untransfected cells (Fig.  3A) . Thus, it is the expression of HLA-G that facilitates the enhanced proliferation of TANK-1, rather than any artefactual alteration in the phenotype of transfected 721.221 cells. Although HLA-G can facilitate action through both NK1 and NK2 receptors, HLA-G-transfected 721.221 cells inhibited the proliferative response of TANK-9 to TSST1 (Fig. 3B) (22) .
Thus, both NK activating receptors and NK inhibitory receptors are present on T cell clones, where they can alter the proliferative response of T cells stimulated by superantigen. NK inhibitory receptors can also inhibit the proliferative response of T cells stimulated by peptide antigen (19) as well as by superantigen (10) , and it is reasonable to infer that NK activating receptors costimulate T cells activated by peptide antigens. Therefore, distinct combinations of activating and inhibitory receptors on each T cell could adjust the response of the human immune system to specific antigens.
Because the presence of an activating , or the choriocarcinoma cell line JEG-3. Proliferation assays were done as described (18) . Each data point was measured in duplicate. The range in each measurement was less than 10% of the mean of the duplicates. The experiments shown here are representative of three data sets that were obtained.
NK receptor on a T cell potentially facilitates a response to small amounts of antigen, it is possible that TANK cells are important in initiating immune responses. In particular, because, by flow cytometry, NK receptors occur primarily on T cells of a memory phenotype (19, 23) , costimulatory NK receptors may especially facilitate the rapid induction of secondary T cell-mediated immune responses. In addition, the expression and function of activating class I MHC receptors may allow activation of a T cell whose TCR may interact weakly with self peptide. Thus, expression of such receptors could also be significant in triggering the onset of autoimmune disease.
